Latest Teva Pharmaceutical Industries Stories
Adasuve® (loxapine) inhalation powder is approved in the U.S. for the acute treatment of agitation associated with schizophrenia and bipolar disorder NORTH WALES, Pa. and MOUNTAIN VIEW, Calif., May 8, 2013 /PRNewswire/ -- Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: TEVA), and Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) announced today that the companies have entered into an exclusive U.S. license and supply agreement for ADASUVE...
Short-Track Speed Skating Champion Encourages Public to Vote for Winner at www.EIBAllStars.com NORTH WALES, Pa., April 16, 2013 /PRNewswire/ -- Apolo Anton Ohno and Teva Respiratory have announced ten finalists in the EIB All Stars contest, part of a national awareness campaign celebrating the determination and accomplishments of people living with exercise-induced bronchospasm (EIB). EIB is an underdiagnosed condition affecting an estimated 30 million Americans, which causes the...
SYDNEY, April 10, 2013 /PRNewswire/ -- Benitec Biopharma Ltd (ASX: BLT), a biopharmaceutical company developing innovative therapeutics based on its gene silencing technology, DNA-directed RNA interference (ddRNAi), is very pleased to report that Mr. Kevin Buchi, CPA, has accepted an invitation to join the Company's Board of Directors. Mr. Buchi served as Chief Executive Officer of Cephalon, Inc. through its $6.8 billion acquisition by Teva Pharmaceutical Industries in October...
-- Patent Expands Company's Patent Portfolio to Include Combination with Number One Selling Multiple Sclerosis Drug -- ROCKVILLE, Md., April 4, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of synthetic biologics and innovative medicines for serious infections and diseases, announced today that the U.S. Patent & Trademark Office has issued U.S. Patent No. 8,372,826 entitled, Estriol Therapy for Multiple Sclerosis and Other Autoimmune...
Walker's Charity, Band Against MS Teams Up with Teva Pharmaceuticals to Launch Public Service Announcement Campaign and Raise Money for MS Research FRAZER, Pa., March 13, 2013 /PRNewswire/ -- Country music singer Clay Walker today announced the launch of "Stick With It!," a national public service announcement campaign to educate relapsing-remitting multiple sclerosis (RRMS) patients about the importance of remaining adherent to a disease management routine for the long-term. Teva...
CHICAGO, March 11, 2013 /PRNewswire/ -- Zacks Equity Research highlights Winnebago Industries, Inc. (NYSE:WGO) as the Bull of the Day and Gold Fields Limited (NYSE:GFI) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Biogen (Nasdaq:BIIB) and Novartis (NYSE:NVS). (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO) Full analysis of all these stocks is available at http://at.zacks.com/?id=2678....
VANCOUVER, Dec. 14, 2012 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: Teva Pharmaceutical (NYSE:TEVA), Skyworks Solutions (NASDAQ:SWKS), Petroleo Brasileiro Petrobras SA (NYSE:PBR), Newmont Mining (NYSE:NEM), Zynga (NASDAQ:ZNGA), and Walgreen (NYSE:WAG). (Logo: http://photos.prnewswire.com/prnh/20121105/HK06856LOGO ) (Read full report by clicking the link below. You may need to copy and paste...
VANCOUVER, Dec. 13, 2012 /PRNewswire/ -- EarningForecast.com has issued consensus earnings forecast reports and equity research for the following companies: American International Group (NYSE:AIG), Teva Pharmaceutical (NYSE:TEVA), CSX (NYSE:CSX), Exxon Mobil (NYSE:XOM), Lowe's (NYSE:LOW), and Seagate (NASDAQ:STX). (Logo: http://photos.prnewswire.com/prnh/20121030/HK02457LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your...
SOUTH JORDAN, Utah and PETACH TIKVAH, Israel, Dec. 12, 2012 /PRNewswire/ -- OphthaliX Inc. (OTCBB: OPLI) today announced that it has appointed Dr. Gil Ben-Menachem as Chief Executive Officer effective January 1, 2013. Dr. Ben-Menachem is a seasoned executive with twelve years of experience in the pharmaceutical, biotechnology, and venture capital industries. Dr. Ben-Menachem joins OphthaliX from Teva Pharmaceutical Industries Ltd., a world leading generic drug maker, where he has...
EAST RUTHERFORD, N.J., Nov. 29, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) announced that Shlomo Yanai was appointed to its Board of Directors yesterday and will serve as its Non-Executive Vice Chairman. Mr. Yanai, who retired in mid-2012 as the President and Chief Executive Officer of Teva Pharmaceutical Industries Ltd., the largest generic pharmaceutical manufacturer in the world, has extensive experience in the life sciences industry. As Vice Chairman of the...
